| Dr James Bryson Mccain, MD | |
|
1120 Kanawha Blvd E, Charleston, WV 25301-2400 | |
| (304) 344-3457 | |
| (304) 344-3480 |
| Full Name | Dr James Bryson Mccain |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 22 Years |
| Location | 1120 Kanawha Blvd E, Charleston, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497956361 | NPI | - | NPPES |
| APPLIED | Medicaid | OH | |
| APPLIED | Medicaid | KY | |
| 3810011355 | Medicaid | WV |
| Facility Name | Location | Facility Type |
|---|---|---|
| Charleston Area Medical Center | Charleston, WV | Hospital |
| Greenbrier Valley Medical Center | Ronceverte, WV | Hospital |
| Roane General Hospital | Spencer, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Radiologists Inc | 1355249749 | 21 |
News Archive
Researchers at Oregon State University have discovered a genetic function that helps one of the most important "tumor suppressor" genes to do its job and prevent cancer.
Q BioMed Inc., a biotechnology acceleration company is pleased to announce it has signed a definitive license, with the option to acquire, the platform technology assets of Mannin Research Inc.
Plexxikon today announced that dosing began in the first of two Phase 1 clinical trials with PLX5622, a novel, oral and highly selective Fms inhibitor, targeted for the treatment of rheumatoid arthritis.
Antares Pharma, Inc. today announced the approval of OTREXUP (methotrexate) injection by the U.S. Food and Drug Administration. OTREXUP is the first FDA approved subcutaneous methotrexate for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the first patient has been treated in a Phase I combination trial of CUDC-101.
› Verified 8 days ago
| Entity Name | Associated Radiologists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649275728 PECOS PAC ID: 1355249749 Enrollment ID: O20031223000024 |
News Archive
Researchers at Oregon State University have discovered a genetic function that helps one of the most important "tumor suppressor" genes to do its job and prevent cancer.
Q BioMed Inc., a biotechnology acceleration company is pleased to announce it has signed a definitive license, with the option to acquire, the platform technology assets of Mannin Research Inc.
Plexxikon today announced that dosing began in the first of two Phase 1 clinical trials with PLX5622, a novel, oral and highly selective Fms inhibitor, targeted for the treatment of rheumatoid arthritis.
Antares Pharma, Inc. today announced the approval of OTREXUP (methotrexate) injection by the U.S. Food and Drug Administration. OTREXUP is the first FDA approved subcutaneous methotrexate for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the first patient has been treated in a Phase I combination trial of CUDC-101.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Bryson Mccain, MD 1120 Kanawha Blvd E, Charleston, WV 25301-2400 Ph: (304) 344-3457 | Dr James Bryson Mccain, MD 1120 Kanawha Blvd E, Charleston, WV 25301-2400 Ph: (304) 344-3457 |
News Archive
Researchers at Oregon State University have discovered a genetic function that helps one of the most important "tumor suppressor" genes to do its job and prevent cancer.
Q BioMed Inc., a biotechnology acceleration company is pleased to announce it has signed a definitive license, with the option to acquire, the platform technology assets of Mannin Research Inc.
Plexxikon today announced that dosing began in the first of two Phase 1 clinical trials with PLX5622, a novel, oral and highly selective Fms inhibitor, targeted for the treatment of rheumatoid arthritis.
Antares Pharma, Inc. today announced the approval of OTREXUP (methotrexate) injection by the U.S. Food and Drug Administration. OTREXUP is the first FDA approved subcutaneous methotrexate for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the first patient has been treated in a Phase I combination trial of CUDC-101.
› Verified 8 days ago
Matthew W. Morris, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1120 Kanawha Blvd E, Charleston, WV 25301 Phone: 304-344-3457 Fax: 304-344-3480 | |
Dr. Mary H.l. Mcjunkin, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1120 Kanawha Blvd E, Charleston, WV 25301 Phone: 304-344-3457 Fax: 304-344-3480 | |
Ravindra K Gogineni, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1021 Quarrier St, Ste 301, Charleston, WV 25301 Phone: 304-343-4625 Fax: 304-343-4626 | |
Dr. John F. Mega, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1120 Kanawha Blvd E, Charleston, WV 25301 Phone: 304-344-3457 Fax: 304-344-3480 | |
Riad Al-asbahi, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1021 Quarrier St, Ste 301, Charleston, WV 25301 Phone: 304-343-4625 Fax: 304-343-4626 | |
Dr. Jennifer M. Smith, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1120 Kanawha Blvd E, Charleston, WV 25301 Phone: 304-344-3457 Fax: 304-344-3480 | |
Timothy Aaron Vanhoose, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1120 Kanawha Blvd E, Charleston, WV 25301 Phone: 304-344-3457 Fax: 304-344-3480 |